Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 4Genitourinary 3Head & Neck 2Endocrine 2Tumor-Agnostic 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Thyroid Cancer, Papillary 1Testicular Neoplasms 1Melanoma 1Adenocarcinoma, Follicular 1

Interventions

Nivolumab 7pembrolizumab 4Ipilimumab 4cemiplimab 3relatlimab 2daromun 2Standard of Care 2Prednisone 2Photochemotherapy 2Melphalan 2Interleukin-2 2Dermoscopy 2Cryotherapy 2Carboplatin 2trametinib 1toripalimab 1tirbanibulin 1sulforaphane 1secukinumab 1gadopiclenol 1famitinib 1decitabine and cedazuridine drug combination 1calcipotriene 1anlotinib 1Watchful Waiting 1Vitamin D 1Vincristine 1Toll-Like Receptor 1 1Therapeutics 1Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Interviews as Topic × Dermatologic × Clear all
NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting
142 enrolled
DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡